Illustration: Sarah Grillo/Axios

Hims, a San Francisco-based direct-to-consumer provider of men's prescription health care products, agreed to go public via a reverse merger with Oaktree Acquisition Corp. (NYSE: OAC), a SPAC formed by Oaktree Capital Management, at an initial valuation of $1.6 billion.

Why it matters: While the pandemic battered many businesses, Hims is within a smaller cohort that the pandemic helped validate, as remote medicine moved mainstream.

Details: The deal includes a $75 million concurrent private placement. Hims, which now also offers women's products, has raised nearly $200 million in VC funding since its 2017 founding from firms like Founders Fund, Forerunner Ventures, IVP, CPPIB, Redpoint Ventures, Thrive Capital and McKesson Ventures.

The bottom line: "We had always expected and prepped for a traditional IPO, but there are a lot of favorable dynamics in the new group of SPACs. There’s greater speed and certainty of a deal, which helps the team stay focused, and we get to partner with an amazing investor like Howard Marks." — Hims CEO Andrew Dudum

Go deeper

Media companies get in on the SPAC action

Illustration: Sarah Grillo/Axios

Special purpose acquisition companies, or SPACs, are booming, and media companies are looking to be a part of the action.

Why it matters: SPACs have become a popular alternative for businesses seeking to go public without undertaking a traditional IPO process.

Dan Primack, author of Pro Rata
Oct 6, 2020 - Economy & Business

Tech investor Chamath Palihapitiya bets big on Medicare Advantage provider

Illustration: Annelise Capossela/Axios

Conventional investor wisdom is to steer clear of next month's election, due to its inherent uncertainty and consequential volatility. But, this morning, Chamath Palihapitiya bet big on a company whose fortunes may be significantly impacted by the presidential victor.

Driving the news: Clover Health, a tech-enabled provider of Medicare Advantage plans, agreed to go public via a reverse merger with a Palihapitiya-led SPAC called Social Capital Hedosophia Holdings III (NYSE: IPOC).

Pence to continue traveling despite aides testing positive for COVID-19

Marc Short with Pence in March. Photo: Drew Angerer/Getty Images

Marc Short, Vice President Mike Pence’s chief of staff, tested positive for the coronavirus Saturday and is quarantining, according to a White House statement.

Why it matters: Short is Pence's closest aide, and was one of the most powerful forces on the White House coronavirus task force. Pence and second lady Karen Pence tested negative for the virus on Sunday morning, according to the vice president's office.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!